Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:HSGX

Histogenics (HSGX) Stock Price, News & Analysis

Histogenics logo

About Histogenics Stock (NASDAQ:HSGX)

Key Stats

Today's Range
$0.85
$0.94
50-Day Range
$0.16
$3.07
52-Week Range
$0.08
$1.43
Volume
4.37 million shs
Average Volume
9.06 million shs
Market Capitalization
$86.89 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Histogenics Corporation develops restorative cell therapies that would offer rapid-onset pain relief and restored function. The company was founded in 2000 and is headquartered in Waltham, Massachusetts.

Receive HSGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Histogenics and its competitors with MarketBeat's FREE daily newsletter.

HSGX Stock News Headlines

Traphaco JSC TRA
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners
Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…
See More Headlines

HSGX Stock Analysis - Frequently Asked Questions

Histogenics Corp (NASDAQ:HSGX) issued its quarterly earnings data on Thursday, August, 9th. The biotechnology company reported ($0.13) earnings per share for the quarter, beating analysts' consensus estimates of ($0.23) by $0.10.

Histogenics (HSGX) raised $60 million in an IPO on Wednesday, December 3rd 2014. The company issued 4,300,000 shares at $13.00-$15.00 per share. Cowen and Company, Needham & Company and Canaccord Genuity acted as the underwriters for the IPO and BTIG was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Histogenics investors own include Interpace Biosciences (IDXG), Verastem (VSTM), Progenics Pharmaceuticals (PGNX), Novavax (NVAX), SCYNEXIS (SCYX), Ocular Therapeutix (OCUL) and OPKO Health (OPK).

Company Calendar

Last Earnings
8/09/2018
Today
11/21/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical Appliances & Supplies
Sub-Industry
N/A
Current Symbol
NASDAQ:HSGX
Fax
N/A
Employees
49
Year Founded
N/A

Profitability

Net Income
$-8,640,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.01) per share

Miscellaneous

Free Float
N/A
Market Cap
$86.89 million
Optionable
Not Optionable
Beta
3.10
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:HSGX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners